v3.26.1
Consolidated Statements Of Cash Flows - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Cash flows from operating activities:      
Net income $ 191 $ (11)  
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 197 191  
Amortization 53 51  
Amortization of deferred debt issuance costs 2 2  
Restructuring expense, net of cash paid 4 (18)  
Deferred income taxes (28) 336  
Pension and other postretirement benefit expenses 17 11  
Loss from equity method investments, net of dividends received 13 10  
Loss on extinguishment of debt 5 3  
Loss on sale of assets 2 0  
Share-based compensation 24 32  
Gain (Loss) on Disposition of Stock in Subsidiary or Equity Method Investee     $ (33)
Changes in operating assets and liabilities:      
Accounts receivable, net (321) (288)  
Inventories (185) (109)  
Other assets (154) (17)  
Accounts payable 133 104  
Accrued and other long-term liabilities (73) (42)  
Other, net (14) 23  
Pension contributions (9) (5)  
Net cash provided by operating activities (143) 273  
Cash flows from investing activities:      
Capital expenditures (219) (197)  
Proceeds from sale of property 0 1  
Cost of technology investments 0 (12)  
Settlement of derivatives (2) 5  
Net cash used in investing activities (221) (203)  
Cash flows from financing activities:      
Net proceeds (repayments) under other short-term debt agreements 13 (279)  
Net proceeds (repayments of) under term loans 486 0  
Repayments of Other Long-Term Debt 0 (250)  
Repayment of senior notes (270) 0  
Proceeds from issuance of senior and junior notes, net of issuance costs 1,577 0  
Fees related to modification of debt agreements 0 5  
Repurchase of ordinary shares (76) 0  
Taxes withheld and paid on employees' restricted share awards (34) (19)  
Net cash used in by financing activities 1,692 (553)  
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash (5) 10  
(Decrease) increase in cash, cash equivalents and restricted cash 1,323 (473)  
Cash, cash equivalents and restricted cash at beginning of period 1,854 1,574 1,574
Cash, cash equivalents and restricted cash at end of period 3,177 1,101 $ 1,854
Capital expenditures included in accounts payable 171 139  
Dividend payments of consolidated affiliates to minority shareholders $ (4) $ 0